Androgen Deprivation Therapy in High-Risk Prostate Cancer

被引：0
作者：
Buyyounouski, Mark K. [1 ]
机构：
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 09期
关键词：
RADIOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：806 / 809
页数：2
相关论文
共 50 条
[21]   Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy [J].
Ludwig, Michelle S. ;
Kuban, Deborah A. ;
Strom, Sara S. ;
Du, Xianglin L. ;
Lopez, David S. ;
Yamal, Jose-Miguel .
AMERICAN JOURNAL OF MENS HEALTH, 2017, 11 (01) :73-81
[22]   Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial [J].
Fizazi, Karim ;
Faivre, Laura ;
Lesaunier, Francois ;
Delva, Remy ;
Gravis, Gwenaelle ;
Rolland, Frederic ;
Priou, Frank ;
Ferrero, Jean-Marc ;
Houede, Nadine ;
Mourey, Loic ;
Theodore, Cnristine ;
Krakowski, Ivan ;
Berdah, Jean-Francois ;
Baciuchka, Marjorie ;
Laguerre, Brigitte ;
Flechon, Aude ;
Ravaud, Alain ;
Cojean-Zelek, Isabelle ;
Oudard, Stephane ;
Labourey, Jean-Luc ;
Chinet-Charrot, Paule ;
Legouffe, Eric ;
Lagrange, Jean-Leon ;
Linassier, Claude ;
Deplanque, Gael ;
Beuzeboc, Philippe ;
Davin, Jean-Louis ;
Martin, Anne-Laure ;
Habibian, Muriel ;
Laplanche, Agnes ;
Culine, Stephane .
LANCET ONCOLOGY, 2015, 16 (07) :787-794
[23]   High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer Are high-risk patients good candidates? [J].
Yoshida, Ken ;
Yamazaki, Hideya ;
Takenaka, Tadashi ;
Kotsuma, Tadayuki ;
Yoshida, Mineo ;
Masui, Koji ;
Yoshioka, Yasuo ;
Narumi, Yoshifumi ;
Oka, Toshitsugu ;
Tanaka, Eiichi .
STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (11) :1015-1020
[24]   Comparison of neoadjuvant vs concurrent/adjuvant androgen deprivation in men with high-risk prostate cancer receiving definitive radiation therapy [J].
Lee, Anna ;
Becker, Daniel J. ;
Lederman, Ariel J. ;
Osborn, Virginia W. ;
Shao, Meng S. ;
Wong, Andrew T. ;
Schwartz, David ;
Schreiber, David .
TUMORI, 2017, 103 (04) :387-393
[25]   Duration of androgen deprivation with radio-therapy for high-risk or locally advanced prostate cancer: A network meta-analysis [J].
Petrelli, Fausto ;
De Stefani, Agostina ;
Vavassori, Ivano ;
Motta, Federica ;
Luciani, Andrea ;
Trevisan, Francesca .
TUMORI JOURNAL, 2023, 109 (04) :424-429
[26]   Avoiding Androgen Deprivation Therapy in Men With High-risk Prostate Cancer: The Role of Radical Prostatectomy as Initial Treatment EDITORIAL COMMENT [J].
Boorjian, Stephen A. ;
Blute, Michael L. .
UROLOGY, 2011, 77 (04) :950-951
[27]   Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation? [J].
Shakespeare, Thomas P. ;
Wilcox, Shea W. ;
Aherne, Noel J. .
ONCOTARGETS AND THERAPY, 2016, 9 :2819-2824
[28]   Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy [J].
Raldow, Ann C. ;
Zhang, Danjie ;
Chen, Ming-Hui ;
Braccioforte, Michelle H. ;
Moran, Brian J. ;
D'Amico, Anthony V. .
BRACHYTHERAPY, 2015, 14 (06) :781-787
[29]   CONCURRENT ANDROGEN DEPRIVATION THERAPY DURING SALVAGE PROSTATE RADIOTHERAPY IMPROVES TREATMENT OUTCOMES IN HIGH-RISK PATIENTS [J].
Soto, Daniel E. ;
Passarelli, Michael N. ;
Daignault, Stephanie ;
Sandler, Howard M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03) :1227-1232
[30]   Changes in Magnetic Resonance Imaging Radiomic Features in Response to Androgen Deprivation Therapy in Patients with Intermediate- and High-risk Prostate Cancer [J].
Tharmalingam, H. ;
Tsang, Y. M. ;
Alonzi, R. ;
Beasley, W. ;
Taylor, N. J. ;
McWilliam, A. ;
Padhani, A. ;
Choudhury, A. ;
Hoskin, P. J. .
CLINICAL ONCOLOGY, 2022, 34 (06) :E246-E253
12345